MDLZ:NASDAQ
Mondelez International, Inc.
Data as of 2026-03-10 - not real-time
$58.17
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Mondelez International trades at $58.17, well above its DCF‑derived fair value of $41.74, implying an overvalued positioning despite a forward P/E of 17.2 versus a trailing P/E of 30.8. The stock yields 3.42% but the payout ratio exceeds 100% (≈102.6%), raising concerns about dividend sustainability. Technical gauges show the price sitting below the 20‑day SMA (60.02) while marginally above the 50‑day SMA (57.94), a neutral trend with a bearish MACD histogram and an RSI of 44.7, suggesting limited upside in the near term.
Revenue grew 9.3% YoY to $38.5 bn, and operating cash flow of $4.5 bn supports the business’s cash‑generating capacity. Analysts remain optimistic, maintaining a Buy consensus and a median price target of $67, indicating a potential 15% upside from current levels. The company’s global brand suite (Oreo, Cadbury, Toblerone) provides defensive exposure, while stable volume and low beta (≈0.09) temper systematic risk. However, 30‑day volatility sits near 26% and the high debt‑to‑equity ratio (≈85%) adds a layer of financial risk.
Revenue grew 9.3% YoY to $38.5 bn, and operating cash flow of $4.5 bn supports the business’s cash‑generating capacity. Analysts remain optimistic, maintaining a Buy consensus and a median price target of $67, indicating a potential 15% upside from current levels. The company’s global brand suite (Oreo, Cadbury, Toblerone) provides defensive exposure, while stable volume and low beta (≈0.09) temper systematic risk. However, 30‑day volatility sits near 26% and the high debt‑to‑equity ratio (≈85%) adds a layer of financial risk.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- price below 20‑day SMA indicating limited short‑term momentum
- bearish MACD histogram and neutral RSI
- valuation gap between market price and DCF fair value
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- analyst consensus Buy with median target $67 (~15% upside)
- solid 9.3% revenue growth and strong operating cash flow
- stable volume and low systematic beta supporting price stability
Long Term
> 3 yearshold
Conviction: 7/10
Key Factors
- global brand portfolio provides defensive resilience
- high dividend payout ratio questions long‑term yield sustainability
- potential for margin improvement as operating efficiency initiatives mature
Key Metrics & Analysis
Financial Health
Revenue Growth9.30%
Profit Margin6.36%
P/E Ratio30.8
ROE9.33%
ROA3.24%
Debt/Equity84.85
P/B Ratio2.9
Op. Cash Flow$4.5B
Free Cash Flow$3.6B
Technical Analysis
TrendNeutral
RSI44.7
Support$57.35
Resistance$62.80
MA 20$60.02
MA 50$57.94
MA 200$61.24
MACDBearish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value$41.74
Target Price$66.96
Upside/Downside15.11%
GradeOvervalued
TypeBlend
Dividend Yield3.42%
Risk Assessment
Beta0.09
Volatility25.82%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.